Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK

Yoshihiro Kobashigawa1, Mieko Sakai, Masato Naito

  • 1Department of Structural Biology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido 060-0810, Japan.

Insights

The linker region of CRKII (SH2-SH3-SH3) protein influences its binding to targets, explaining distinct biological activities compared to CRKI (SH2-SH3). This impacts cell growth and motility regulation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • CRK proteins (CRKI and CRKII) are oncoproteins regulating cell growth and motility.
  • Distinct biological activities of CRKI and CRKII isoforms are not fully understood.
  • CRKI exhibits significant transforming activity, while CRKII has low activity, and phosphorylated CRKII is inactive.

Purpose of the Study:

  • To elucidate the molecular mechanisms behind the differing biological activities of CRKI and CRKII.
  • To determine the solution structures of CRKI, CRKII, and phosphorylated CRKII.
  • To investigate the role of the linker region in CRK protein function.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) spectroscopy to determine protein structures.
  • Mutational analysis in rodent 3Y1 fibroblasts.
  • Structural studies and mutational analysis integration.

Main Results:

  • Solution structures of CRKI, CRKII, and phosphorylated CRKII were determined.
  • The linker region was identified as a key modulator of CRKII target binding.
  • Mutational analysis results corroborated the structural findings.

Conclusions:

  • The linker region's modulation of CRKII binding explains its distinct biological activities.
  • Understanding these mechanisms provides insight into cell growth and motility regulation.
  • This study clarifies the structure-function relationship of CRK protein isoforms.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...